Background Image
Table of Contents Table of Contents
Previous Page  71 / 88 Next Page
Basic version Information
Show Menu
Previous Page 71 / 88 Next Page
Page Background

71

David Antonio Rodríguez Fuentes

Espectro clínico y genético de la muerte súbita cardíaca en el deporte

21. Risgaard B, Winkel BG, Jabbari R, Glinge C, Ingemann-Hansen

O, Thomsen JL, et al. Sports-related sudden cardiac death in

a competitive and a noncompetitive athlete population aged

12 to 49 years: data from an unselected nationwide study in

Denmark. Heart Rhythm 2014;11:1673–1681.

22. Holst AG, Winkel BG, Theilade J, Kristensen IB, Thomsen

JL, Ottesen GL, et al. Incidence and etiology of sports-

related sudden cardiac death in Denmark—implications for

preparticipa- tion screening. Heart Rhythm 2010;7:1365–

1371.

23. Jiménez-Jáimez J, Alvarez M, Algarra M, Macías-Ruíz R,

Peñas R, Valverde F, et al et al. Low clinical penetrance in

causal mutation carriers for cardiac channelopathies. Rev Esp

Cardiol. 2013;66:275–81

24. Eloi Marijon, Audrey Uy-Evanado, Florence Dumas, Nicole

Karam, Kyndaron Reinier, Carmen Teodorescu, et al. Warning

Symptoms Are Associated With Survival From Sudden Cardiac

Arrest. Annals of Internal Medicine 2015; DOI:

10.7326/M14- 2342

25. Hansen CM, Wissenberg M, Weeke P, Ruwald MH, Lamberts

M, Lippert F, et al. Automated external defibrillators

inaccessible to more than half of nearby cardiac arrests in

public locations during evening, nighttime and weekends.

Circulation 2013;128: 2224–2231.

26. Wissenberg M, Lippert FK, Folke F, P Weeke, CM Hansen,

Christensen EF, et al. Association of national initiatives to

improve cardiac arrest management with rates of bystander

intervention and patient survival after out-of-hospital cardiac

arrest. JAMA 2013;310:1377–1384.

27. Tester DJ, Ackerman MJ. Postmortem long QT syndrome

genetic testing for sudden unexplained death in the young. J

Am Coll Cardiol 2007;49:240-6.

28. Tester DJ, Ackerman MJ. The role of molecular autopsy

in unexplained sudden cardiac death. Curr Opin Cardiol

2006;21:166-172.

29. Ackerman MJ, Priori SG, Willems S, Berul C, Brugada R, Calkins

H, et al. HRS/EHRA expert consensus statement on the state of

genetic testing for the channelopathies and cardiomyopathies:

this document was developed as a partnership between the

Heart Rhythm Society (HRS) and the European Heart Rhythm

Association (EHRA). Heart Rhythm 2011;8:1308-39

30. Monserrat L, Ortiz-Genga M, Lesende I, Garcia-Giustiniani

D, Barriales-Villa R, de Una-Iglesias D et al. Genetics of

cardiomyopathies: novel perspectives with next generation

sequencing. Curr Pharm Des. 2015;21:418-30.